// App-Quantinova.ai

: A Multicentre Study of Anticoagulation in Operable Chronic Thromboembolic Pulmonary Hypertension

Researchers

Presenter

  • K. Bunclark

Principal Investigators

  • Y. Chiu

  • A. Ruggiero

  • S. Villar

  • J. Cannon

  • G. Coghlan

  • P. A. Corris

  • L. Howard

  • D. Jenkins

  • M. Johnson

  • D. Kiely

  • C. Ng

  • N. Screaton

  • K. Sheares

  • D. Taboada

  • S. Tsui

  • J. Wort

  • J. Pepke-Zaba

  • M. Toshner

Medical Centers

  • Papworth Hospital, Cambridge, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

  • Freeman Hospital, Newcastle upon Tyne, United Kingdom

  • National Heart and Lung Institute, London, United Kingdom

  • Golden Jubilee National Hospital, Clydebank, United Kingdom

  • Royal Hallamshire Hospital, Sheffield, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Autoimmune (AI)

  • Gastroenterology (GU)

Disease

  • Chronic thromboembolic pulmonary hypertension

  • Antiphospholipid syndrome

  • Abdominal aortic aneurysm

  • Gastrointestinal bleeding

  • Pulmonary embolism

  • Pulmonary arterial hypertension

  • Venous thrombosis

  • Hypertension

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved